Recommendations and feedback from the European Bioanalysis Forum Workshop: 1 year into ICH M10 – keeping our finger on the pulse

The ICH M10 guideline on bioanalytical method validation and sample analysis is being adopted since 2023. However, and inevitably, some paragraphs or requirements remain ambiguous and are open for different interpretations. In support of a harmonized interpretation by the industry and health authori...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioanalysis 2024-03, Vol.16 (5), p.259-270
Hauptverfasser: Timmerman, Philip, Barfield, Matthew, Portabella, Enric Bertran, Calogero, Salvatore, Cowan, Kyra, Faber, Jörg, Ferrari, Luca, Golob, Michaela, Goodman, Jo, Goodwin, Lee, Gnoth, Mark Jean, Hughes, Richard, Ivanova, Tsvetelina, Jordan, Gregor, Laurén, Anna, Maux, Delphine, McDougall, Stuart, Milushewa, Petya, Nelson, Robert, Pynaert, Gwenda, Sklodowski, Kamil, Sleigh, Rebecca, Struwe, Petra, Verhaeghe, Tom, Wheller, Robert, White, Steve, Zeiser, Katja
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The ICH M10 guideline on bioanalytical method validation and sample analysis is being adopted since 2023. However, and inevitably, some paragraphs or requirements remain ambiguous and are open for different interpretations. In support of a harmonized interpretation by the industry and health authorities, the European Bioanalysis Forum organized a workshop on 14 November 2023 in Barcelona, Spain, to discuss unclear and/or ambiguous paragraphs which were identified by the European Bioanalysis Forum community and delegates of the workshop prior to the workshop. This manuscript reports back from the workshop with recommendations and aims at continuing an open scientific discussion within the industry and with regulators in support of a science-driven guideline for the bioanalytical community and in line with the ICH mission – that is, achieve greater harmonization worldwide to ensure that safe, effective and high-quality medicines are developed and registered in the most resource-efficient manner.
ISSN:1757-6180
1757-6199
DOI:10.4155/bio-2024-0013